Management Buyout of Winner Medical - Shareholder Investigation by Tripp Levy PLLC on Behalf of Winner Medical Group Shareholders
Published: Apr 02, 2012
NEW YORK, April 2, 2012 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities law firm, is investigating the Board of Directors of Winner Medical Group Inc. ("Winner" or the "Company") (Nasdaq:WWIN) for possible breaches of fiduciary duty and other violations of state law in connection with the receipt of a going private proposal from its Chairman and Chief Executive Officer, Mr. Jianquan Li. According to the terms of the proposal, Li would acquire all outstanding shares of the Company's common stock for $4.30 per share. Li currently owns approximately 74% of the Company's stock.
The investigation concerns, among other things, whether the consideration to be paid to Winner shareholders is unfair, inadequate, and substantially below the fair or inherent value of Winner, and whether Li is a controlling shareholder that is taking advantage of his position to purchase the Company at an unfair price. Indeed, analysts project the stock of Winner is worth at least $6.27 per share, and the company's book value alone is $5.31 per share.
If you own common stock in Winner and wish to obtain additional information, please contact us at:
Tripp Levy PLLC
Toll free: 877-772-3975
SOURCE Tripp Levy PLLC